Deciphering the particle specific effects on metabolism in rat liver and plasma from ZnO nanoparticles versus ionic Zn exposure. (March 2020)

• Record Type: Journal Article
• Authors: Guo, Zhiling; Luo, Yali; Zhang, Peng; Chetwynd, Andrew J.; Qunhui Xie, Heidi; Abdolahpur Monikh, Fazel; Tao, Wunqun; Xie, Changjian; Liu, Yiyun; Xu, Li; Zhang, Zhiyong; Valsami-Jones, Eugenia; Lynch, Iseult; Zhao, Bin
• Is Part Of: Environment international. Volume 136(2020)
• Publication Date: 2020-03
• Subjects: Zinc oxide nanoparticles -- Zinc ions -- Metabolite profile -- Energy metabolism, oxidative stress; Environmental protection -- Periodicals; Environmental health -- Periodicals; Environmental monitoring -- Periodicals; Environmental Monitoring -- Periodicals; Environnement -- Protection -- Périodiques; Hygiène du milieu -- Périodiques; Environnement -- Surveillance -- Périodiques; Environmental health; Environmental monitoring; Environmental protection; Periodicals; 333.705
• DOI: 10.1016/j.envint.2019.105437
• Languages: English
• ISSNs: 0160-4120

Abstract

Graphical abstract: Highlights: Intranasal exposure to ZnO NPs induced accumulation of Zn in liver of rat. No accumulation of Zn in liver was found in ZnSO4 treatment. Persistence of NPs in liver 7 days post exposure was revealed by XAFS. More and distinct metabolites in liver were altered by ZnO NPs than by ZnSO4 . ZnO NPs induced particle-specific effects revealed by metabolomics. Abstract: Toxicity of ZnO nanoparticles (NPs) are often related to the release of Zn 2+ ions due to their dissolution. Studies also suggest that the toxicity of ZnO NPs cannot be solely explained by the release of Zn 2+ ions; however, there is a lack of direct evidence of ZnO particulate effects. This study compared the acute toxicity of ZnO NPs and ZnSO4 following intranasal exposure using a combination of metallomics and metabolomics approaches. Significant accumulation of Zn in the liver was only found in the ZnO NP treatment, with 29% of the newly accumulated Zn in the form of ZnO as revealed by X-ray fine structure spectroscopy (XAFS). This is the first direct evidence suggesting the persistence of ZnO NPs in liver upon intranasal exposure. Although both ZnO NPs and ZnSO4 altered the metabolite profiles, with some overlaps and considerable specificity, of both liver and plasma samples, more and distinct metabolites in the liver and opposite effects in the plasma were altered by ZnO NPs compared with ZnSO4, consistent with no accumulation of Zn detected in liver from ZnSO4 . Specifically, a large number of antioxidant-related compounds and energetic substrates were exclusively elevated in the liver of ZnO NP-treated animals. These findings provided direct evidence that persistence of ZnO NPs induced particle-specific effects on the antioxidant systems and energy metabolism pathways.